Back to News
Market Impact: 0.2
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
Source: zacks.com
Analyst EstimatesHealthcare & BiotechInvestor Sentiment & Positioning
Ginkgo Bioworks shares were a notable recent mover on above-average trading volume, but unfavorable earnings-estimate revision trends may limit further near-term upside. The article provides no specific price, volume, or estimate-revision figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
DNA-0.35
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Palantir’s revenue rises 96% to $2.3 billion as investors’ patience rests on a hair trigger
- Binance seeks to shore up confidence after record $6.3 billion heist
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Ackman’s Pershing Square adds seven investments in 2026, reports Q3 loss
- Why is Apple stock falling afterhours today?